Precision BioSciences Management
Management criteria checks 3/4
Precision BioSciences' CEO is Michael Amoroso, appointed in Oct 2021, has a tenure of 2.5 years. total yearly compensation is $4.37M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 0.17% of the company’s shares, worth $152.90K. The average tenure of the management team and the board of directors is 3 years and 4.3 years respectively.
Key information
Michael Amoroso
Chief executive officer
US$4.4m
Total compensation
| CEO salary percentage | 13.8% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts
Aug 06
It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks
Jun 23Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?
Mar 14Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?
Dec 08Precision BioSciences appoints chief business officer from within ranks, rejigs co-founders' roles
Sep 02Precision BioSciences: CAR T Data Updates End Of 2022 And Plenty Of Cash
Aug 16Precision BioSciences Q2 2022 Earnings Preview
Aug 05Precision Bio: Another CAR-T Laggard With No Solid Prospects
May 09Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt
Apr 19Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)
Mar 21Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely
Dec 31Precision BioSciences: Uniquely Positioned
Oct 07Is Precision BioSciences (NASDAQ:DTIL) A Risky Investment?
Sep 24Precision BioSciences: The Right Profile To Progress
Aug 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$43m |
| Sep 30 2023 | n/a | n/a | -US$87m |
| Jun 30 2023 | n/a | n/a | -US$89m |
| Mar 31 2023 | n/a | n/a | -US$109m |
| Dec 31 2022 | US$4m | US$604k | -US$73m |
| Sep 30 2022 | n/a | n/a | -US$76m |
| Jun 30 2022 | n/a | n/a | -US$93m |
| Mar 31 2022 | n/a | n/a | -US$40m |
| Dec 31 2021 | US$6m | US$127k | -US$31m |
Compensation vs Market: Michael's total compensation ($USD4.37M) is above average for companies of similar size in the US market ($USD674.64K).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Amoroso (44 yo)
2.5yrs
Tenure
US$4,368,115
Compensation
Mr. Michael Amoroso serves as Director, President and Chief Executive Officer of Precision BioSciences, Inc. since October 15, 2021. He serves as Director at Abeona Therapeutics Inc. since March 19, 2021 a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$4.37m | 0.17% $ 152.9k | |
| CFO & Principal Accounting Officer | 3.3yrs | US$2.38m | 0.30% $ 263.5k | |
| General Counsel & Secretary | 4.8yrs | US$1.51m | 0.073% $ 64.8k | |
| Co-Founder & Chief Research Officer | no data | no data | 1.07% $ 954.6k | |
| Director of Investor Relations & Finance | no data | no data | no data | |
| Vice President of Quality & Compliance | 4.3yrs | no data | no data | |
| Senior Director of Corporate Communications | no data | no data | no data | |
| Chief People Officer | 1.9yrs | no data | no data | |
| Head of Manufacturing | no data | no data | no data | |
| Chief Medical Officer | 3yrs | no data | 0.046% $ 40.7k | |
| Chief Business Officer | no data | no data | no data | |
| Senior VP and Head of Chemistry | 1.2yrs | no data | no data |
3.0yrs
Average Tenure
50yo
Average Age
Experienced Management: DTIL's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$4.37m | 0.17% $ 152.9k | |
| Member of Scientific Advisory Board | 6.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.3yrs | US$256.47k | no data | |
| Independent Chairman | 4.4yrs | US$324.67k | 0.0027% $ 2.4k | |
| Independent Director | 4.1yrs | US$271.14k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$251.38k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$259.61k | 0% $ 0 | |
| Independent Director | 1.9yrs | US$442.49k | 0% $ 0 | |
| Member of Scientific Advisory Board | 5.3yrs | no data | no data | |
| Independent Director | 3yrs | US$257.64k | 0.00072% $ 640.9 |
4.3yrs
Average Tenure
66yo
Average Age
Experienced Board: DTIL's board of directors are considered experienced (4.3 years average tenure).